NIMI
ABMD

Natixis Investment Managers International’s Abiomed Inc ABMD Stock Holding History

Natixis Investment Managers International’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,151
Closed -$1.87M – 605
2018
Q3 		$1.87M Buy
+4,151
New +$1.64M 0.09% 211
2017
Q4 		– Sell
-656
Closed -$111K – 371
2017
Q3 		$111K Buy
+656
New +$99.2K 0.01% 358

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Natixis Investment Managers International's ABMD Position: Q4 2018 in Review

Natixis Investment Managers International sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 4,151 shares — an estimated $1.87M sold.

Natixis Investment Managers International first reported a position in ABMD in Q3 2017 and held it in 2 quarters. The position peaked at $1.87M in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Natixis Investment Managers International reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 4,151 Abiomed Inc shares in Q4 2018, an estimated $1.87M.
  • Natixis Investment Managers International first reported a position in Abiomed Inc in Q3 2017 and held it in 2 quarters.
  • Natixis Investment Managers International's Abiomed Inc position peaked at $1.87M in Q3 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Natixis Investment Managers International's 13F filing for Q4 2018, filed 14 Feb 2019.